These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31951186)

  • 41. Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Iwaszkiewicz C; Puszczewicz M; Białkowska-Puszczewicz G
    Int J Rheum Dis; 2015 Jan; 18(1):46-51. PubMed ID: 25488711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.
    Hashem S; Mahmoud A; Fahmy H; Habeib R; Eltigani S
    Egypt J Immunol; 2012; 19(2):9-12. PubMed ID: 23885402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
    Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
    Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide.
    Park M; Pyun JC; Akter H; Nguyen BT; Kang MJ
    J Pharm Biomed Anal; 2015 Nov; 115():107-13. PubMed ID: 26177216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of anti-CCP antibody for diagnosis of rheumatoid arthritis.
    Afzal N; Karim S; Mahmud TE; Sami W; Arif M; Abbas S
    Clin Lab; 2011; 57(11-12):895-9. PubMed ID: 22239019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic significance of combined detection of rheumatoid factor and anticyclic citrullinated peptide antibodies in rheumatoid arthritis].
    Mu R; Sun XY; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):498-500. PubMed ID: 16224521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
    Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
    Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
    El-Banna H; Jiman-Fatani A
    BMC Musculoskelet Disord; 2014 Nov; 15():379. PubMed ID: 25406539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
    Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antibodies cyclic citrullinated peptides (anti-CCP) positivity could be a promising marker in brucellosis patients presented with peripheric arthritis.
    Gokhan A; Turkeyler IH; Babacan T; Pehlivan Y; Dag MS; Bosnak VK; Namiduru M; Kisacik B; Onat AM
    Mod Rheumatol; 2014 Jan; 24(1):182-7. PubMed ID: 24261776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
    Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
    Yang CL; Zhou YR; Zhou F; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
    Ramos-Remus C; Castillo-Ortiz JD; Aguilar-Lozano L; Padilla-Ibarra J; Sandoval-Castro C; Vargas-Serafin CO; de la Mora-Molina H; Ramos-Gomez A; Sanchez-Ortiz A; Avila-Armengol H; Aceves-Avila FJ
    Arthritis Rheumatol; 2015 Nov; 67(11):2837-44. PubMed ID: 26245885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Retrospective Study: The Significance of Combined Testing of Serum Markers for Diagnosis of Rheumatoid Arthritis.
    Mu F; Wu H; Wang Y
    Med Sci Monit Basic Res; 2017 Aug; 23():295-303. PubMed ID: 28855496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic utility of the Elecsys anti-CCP assay in patients with rheumatoid arthritis.
    Ye H; Chen F; Yan S; Zhang Y; Fang Z; Su X; Cai W; Zhang Z
    Mod Rheumatol; 2014 Jul; 24(4):580-4. PubMed ID: 24252038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.